Abstracts

612 – Epigenetic Age Advancement Predicts Cognitive Performance in Older People With HIV

Background Epigenetic studies have shown an accelerated epigenetic age phenotype in people with HIV (PWH). Accelerated epigenetic age has been linked to various disease outcomes including cognitive dysfunction. However, whether epigenetic age estimates predict cognitive measures in PWH remains understudied. Methods PWH age 50 and older were recruited at an urban academic medical. Participants provided…

606 – Single-Nucleus Multiomics Reveals Dysfunction in Multiple Glial Cell Types in Brain Tissue of PWH

Background Central nervous system (CNS) dysfunction is a recognized complication in some people with HIV (PWH). As part of SCORCH (a large-scale, consortium-wide effort examining transcriptional and epigenetic alterations in the brains of PWH), we aim to identify key cell populations and pathways affected by HIV that may be targeted in therapies for HIV-associated CNS…

609 – A Transcriptional Signature of Induced Neurons Differentiates PWH on cART From People Without HIV

Background Neurocognitive impairment (NCI) is a prevalent and important co-morbidity in virologically suppressed people living with HIV (PWH), yet the underlying mechanisms remain elusive and effective treatments lacking. Given the limitations in models adequately replicating neuronal biology and injury in PWH, we explored the use of participant-derived directly induced neurons (iNs) for this purpose.  iNs have…

592 – Plasma Inflammation Is Associated With Brain Cellularity in Diffusion-Based Spectral Imaging in HIV

Background Elevated levels of inflammation and neurodegeneration in the brain and periphery are associated with worse brain health outcomes in persons without HIV (PWoH). People with HIV (PWH) may have greater peripheral inflammation and neurodegeneration that may cause elevated brain inflammation and white matter changes. Brain inflammation can be measured using diffusion-based spectral imaging (DBSI)…

633 – Plasma Neopterin as a Potential Biomarker for Neurocognitive Impairment in Aging People With HIV

Background Neopterin, a biomarker of immune activation, has been widely studied in cerebrospinal fluid as a correlate of neuroinflammation and neurocognitive impairment (NCI) in people with HIV (PWH). Recent evidence suggests that plasma neopterin could be useful in identifying PWH at risk of developing NCI. This study explores neopterin as a potential plasma biomarker for NCI using…

926 – Cognitive Trajectories 1 Year Before and After COVID-19 in an Early-Treated HIV Cohort

Background There is accumulating evidence that SARS-CoV-2 infection may have lasting effects on cognition in a subset of individuals. However, there is scarce data on the impact of COVID-19 on cognitive performance in people with HIV (PWH), who may experience cognitive impairment despite viral suppression by antiretroviral therapy (ART). We examined the trajectory of cognitive parameters 1…

638 – Systemic Immune-Inflammation Index Links to Slower Psychomotor Speed in Older People With HIV

Background Persistent inflammation and immune activation are hallmark features of HIV disease, and associated with long-term brain health disorders, such as neurocognitive impairment even in treated people with HIV (PWH). As PWH age, the interactions between aging, inflammation, and brain health are important to understand. The Systemic Immune-Inflammation Index (SII) has prognostic value as an indicator…

636 – Association of Delayed HIV Diagnosis or ART Initiation With Risk of Age-Associated Dementia

Background Recent studies have reported that older adults with HIV infection are at elevated risk of age-associated dementia despite antiretroviral therapy (ART). We investigated the hypothesis that delayed HIV diagnosis or initiation of ART could contribute to greater risk of developing dementia later in life.  Methods We conducted a retrospective cohort study of people with…

614 – Differential Effects of CB2 Agonism on HIV Replication and Inflammatory Activation in Myeloid Cells

Background Evidence indicates that brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS). Data also suggest that the inflammatory activity of these cells is associated with HIV-associated cognitive impairment. We investigated whether cannabinoid receptor (CB) 2 (CB2), an immunomodulatory receptor expressed in myeloid cells,…